Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | EGFR | P00533 | 2/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TOP1 | P11387 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7565247 | 0.87 | KMT2A (0.58) | KMT2AEGFRFFAR4 | |
| SCHEMBL8993220 | 0.85 | EGFR (0.58) | KMT2AEGFRHDAC3HDAC4HDAC1 | |
| SCHEMBL24440159 | 0.84 | CYP1A2 (0.51) | KMT2AEGFRHDAC3HDAC4HDAC1 | |
| SCHEMBL28062991 | 0.84 | KMT2A (0.57) | KMT2AEGFRHDAC3HDAC4HDAC1 | |
| Acetic Acid SCHEMBL28553657 | 0.83 | POLB (0.48) | KMT2AHDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL3062707 | 0.83 | HTR2A (0.47) | KMT2AHDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL29639019 | 0.82 | HTR2A (0.58) | KMT2AHDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL261028 | 0.82 | HTR2A (0.58) | KMT2AHDAC3HDAC4HDAC7HDAC8 | |
| SCHEMBL3136529 | 0.79 | EGFR (0.54) | KMT2AEGFRHDAC3HDAC4HDAC7 | |
| SCHEMBL1853371 | 0.79 | KMT2A (0.64) | KMT2AEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7759473-B2 | Nucleotide oligomer, nucleotide polymer, method for determining structure of functional substance and method for manufacturing functional substance | FUJITSU LIMITED (JP) | 2010-07-20 | — | — | US | disclosed |
| US-20080300393-A1 | Nucleotide oligomer, nucleotide polymer, method for determining structure of functional substance and method for manufacturing functional substance | FUJITSU LIMITED (JP) | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080300393-A1 | Nucleotide oligomer, nucleotide polymer, method for determining structure of functional substance and method for manufacturing functional substance | RNMT, NT5C3B, ADAR | KMT2A 3703/4885EGFR 2592/4885HDAC3 4730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.